• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Decline and Rebound in Routine Cancer Screening Rates During the COVID-19 Pandemic.

作者信息

McBain Ryan K, Cantor Jonathan H, Jena Anupam B, Pera Megan F, Bravata Dena M, Whaley Christopher M

机构信息

RAND Corporation, Boston, MA, USA.

RAND Corporation, Santa Monica, CA, USA.

出版信息

J Gen Intern Med. 2021 Jun;36(6):1829-1831. doi: 10.1007/s11606-021-06660-5. Epub 2021 Mar 19.

DOI:10.1007/s11606-021-06660-5
PMID:33742300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7978463/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3663/8175481/24741d962ee4/11606_2021_6660_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3663/8175481/24741d962ee4/11606_2021_6660_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3663/8175481/24741d962ee4/11606_2021_6660_Fig1_HTML.jpg

相似文献

1
Decline and Rebound in Routine Cancer Screening Rates During the COVID-19 Pandemic.2019年冠状病毒病大流行期间常规癌症筛查率的下降与反弹
J Gen Intern Med. 2021 Jun;36(6):1829-1831. doi: 10.1007/s11606-021-06660-5. Epub 2021 Mar 19.
2
Cancer screening and COVID-19 pandemic.癌症筛查与新冠疫情
Rev Assoc Med Bras (1992). 2021 Dec;67(12):1748. doi: 10.1590/1806-9282.20210807.
3
Delayed access to lung cancer screening and treatment during the COVID-19 pandemic: Are we headed for a lung cancer pandemic?2019冠状病毒病大流行期间肺癌筛查与治疗的延迟获取：我们是否正走向肺癌大流行？
Respirology. 2021 Feb;26(2):145-146. doi: 10.1111/resp.13996. Epub 2020 Dec 15.
4
Colorectal cancer screening and the COVID-19 pandemic - Lessons learnt.结直肠癌筛查与新冠疫情——经验教训
Prev Med. 2021 Oct;151:106539. doi: 10.1016/j.ypmed.2021.106539. Epub 2021 Jun 30.
5
Delay in Cancer Screening and Diagnosis During the COVID-19 Pandemic: What Is the Cost?新冠疫情期间癌症筛查和诊断的延误：代价是什么？
Oncology (Williston Park). 2020 Sep 15;34(9):343. doi: 10.46883/ONC.2020.3409.0343.
6
Cessation of cancer screening: An unseen cost of the COVID-19 pandemic?癌症筛查的中断：新型冠状病毒肺炎大流行的一项隐性成本？
Eur J Surg Oncol. 2020 Nov;46(11):2154-2155. doi: 10.1016/j.ejso.2020.05.004. Epub 2020 May 11.
7
[Collateral damages of the Covid-19 pandemic in breast cancer screening].[新冠疫情对乳腺癌筛查的附带损害]
Salud Publica Mex. 2021 Jun 18;63(4):461. doi: 10.21149/12525.
8
Routine Cancer Screening Rates Rebound After Deep Drop From Pandemic Fear.常规癌症筛查率在因疫情恐惧而大幅下降后出现反弹。
CA Cancer J Clin. 2021 Sep;71(5):366-368. doi: 10.3322/caac.21692. Epub 2021 Aug 4.
9
Molecular-based Alternatives for Colorectal Cancer Screening during the COVID-19 Pandemic.2019年冠状病毒病大流行期间基于分子的结直肠癌筛查替代方法
Surg Technol Int. 2020 May 28;36:143-147.
10
Provision of essential bronchoscopy during COVID-19 pandemic.在 COVID-19 大流行期间提供基本支气管镜检查。
Respirology. 2021 May;26(5):509-510. doi: 10.1111/resp.14034. Epub 2021 Mar 7.

引用本文的文献

1
Cancer Screening Progress and Noninvasive Screening Opportunities since the Onset of the COVID-19 Pandemic.自新冠疫情爆发以来的癌症筛查进展与非侵入性筛查机遇
Cancer Prev Res (Phila). 2025 Jun 2;18(6):313-319. doi: 10.1158/1940-6207.CAPR-25-0007.
2
Eligibility for and reach of the National Breast and Cervical Cancer Early Detection Program, 2018-2021.2018 - 2021年国家乳腺癌和宫颈癌早期检测项目的资格条件及覆盖范围
Cancer Causes Control. 2025 May;36(5):531-538. doi: 10.1007/s10552-024-01947-4. Epub 2025 Jan 8.
3
Strategies for Identifying and Recruiting Women at High Risk for Breast Cancer for Research Outside of Clinical Settings: Observational Study.
在临床环境之外识别和招募高乳腺癌风险女性进行研究的策略：观察性研究。
J Med Internet Res. 2024 Sep 2;26:e54450. doi: 10.2196/54450.
4
Impact of the SARS-CoV-2 on the journey of high-risk colon cancer patients within the scope of the Unified Health System in Brazil.新型冠状病毒对巴西统一卫生系统范围内高危结肠癌患者治疗过程的影响。
BMC Health Serv Res. 2023 Oct 16;23(1):1102. doi: 10.1186/s12913-023-10083-9.
5
Variation in Receipt of Cancer Screening and Immunizations by 10-year Life Expectancy among U.S. Adults aged 65 or Older in 2019.2019 年美国 65 岁或以上成年人按预期寿命 10 年的差异接受癌症筛查和免疫接种的情况。
J Gen Intern Med. 2024 Feb;39(3):440-449. doi: 10.1007/s11606-023-08439-2. Epub 2023 Oct 2.
6
The 2020 US cancer screening deficit and the timing of adults' most recent screen: a population-based cross-sectional study.2020 年美国癌症筛查不足与成年人最近一次筛查的时间：基于人群的横断面研究。
Fam Med Community Health. 2023 Sep;11(3). doi: 10.1136/fmch-2022-001893.
7
Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study.探讨在联邦合格健康中心执业的临床医生中，COVID-19 大流行对宫颈癌筛查实践的感知影响：一项混合方法研究。
Elife. 2023 Sep 4;12:e86358. doi: 10.7554/eLife.86358.
8
Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment.考察临床医生特征与 COVID-19 大流行期间宫颈癌筛查和阴道镜检查实践感知变化之间的关联：一项混合方法评估。
Elife. 2023 Sep 1;12:e85682. doi: 10.7554/eLife.85682.
9
A Survey of Cancer Risk Behaviors, Beliefs, and Social Drivers of Health in New Hampshire and Vermont.新罕布什尔州和佛蒙特州的癌症风险行为、信念和健康社会驱动因素调查。
Cancer Res Commun. 2023 Aug 29;3(8):1678-1687. doi: 10.1158/2767-9764.CRC-23-0267. eCollection 2023 Aug.
10
The Impact of the COVID-19 Pandemic on Breast and Cervical Cancer Screening: A Systematic Review.《COVID-19 大流行对乳腺癌和宫颈癌筛查的影响：系统评价》。
In Vivo. 2023 Jul-Aug;37(4):1455-1476. doi: 10.21873/invivo.13230.